Holen Sie sich die Stockscreener-App
0.934
9.19%
0.0786
Handel nachbörslich:
.92
-0.014
-1.50%
Schlusskurs vom Vortag:
$0.8554
Offen:
$0.87
24-Stunden-Volumen:
1.28M
Relative Volume:
0.89
Marktkapitalisierung:
$72.66M
Einnahmen:
$525.00K
Nettoeinkommen (Verlust:
$-44.76M
KGV:
-1.4041
EPS:
-0.6652
Netto-Cashflow:
$-37.46M
1W Leistung:
+11.74%
1M Leistung:
-26.46%
6M Leistung:
-44.40%
1J Leistung:
-64.62%
1-Tages-Spanne:
$0.87
$0.9387
1-Wochen-Bereich:
$0.7566
$0.9387
52-Wochen-Spanne:
$0.7566
$3.31
Cardiff Oncology Inc Stock (CRDF) Company Profile
Firmenname
Cardiff Oncology Inc
Sektor
Branche
Telefon
858-952-7570
Adresse
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Compare CRDF vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRDF
Cardiff Oncology Inc
|
0.934 | 65.03M | 525.00K | -44.76M | -37.46M | -0.6652 |
VRTX
Vertex Pharmaceuticals Inc
|
470.72 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
759.24 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
830.79 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
182.45 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
313.77 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Eingeleitet | Noble Capital Markets | Outperform |
| 2025-07-08 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2025-06-24 | Eingeleitet | Jefferies | Hold |
| 2024-09-06 | Eingeleitet | Craig Hallum | Buy |
| 2022-01-05 | Eingeleitet | William Blair | Outperform |
| 2021-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-08-09 | Fortgesetzt | Maxim Group | Buy |
| 2020-10-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-10-08 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Cardiff Oncology Inc Aktie (CRDF) Neueste Nachrichten
Cardiff Oncology Inc (CRDF) Valuation: PE, PB & Fair Value Analysis - TradingKey
BlackRock (CRDF holder) discloses 863,259 Cardiff Oncology shares in 13G/A - Stock Titan
Cardiff Oncology Inc (CRDF) Balance Sheet - TradingKey
CRDF|Cardiff Oncology Inc|Price:0.827|Chg%:-0.011 - TradingKey
Cardiff Oncology Inc (CRDF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cardiff Oncology Inc (CRDF) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cardiff Oncology Inc (CRDF) Institutional Confidence - TradingKey
Cardiff Oncology Inc (CRDF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cardiff Oncology Inc (CRDF) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cardiff Oncology Inc (CRDF) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cardiff Oncology Inc (CRDF) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cardiff Oncology Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Cardiff Oncology Inc (CRDF) Cash Flow - TradingKey
CRDF|Cardiff Oncology Inc|Price:0.831|Chg%:+0.004 - TradingKey
CRDF|Cardiff Oncology Inc|Price:0.845| - TradingKey
TradingKey - TradingKey
Cardiff Oncology Inc (CRDF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cardiff Oncology, Inc. (CRDF) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Cardiff Oncology completes $10 million financing transaction - TipRanks
Cardiff Oncology CEO Mani Mohindru buys $49,999 of common stock - Investing.com UK
Cardiff Oncology (CRDF) Proxy filing Summary - Quartr
Insider Buying: Mani Mohindru Acquires Shares of Cardiff Oncology Inc (CRDF) - GuruFocus
Cardiff Oncology CEO Mani Mohindru buys $49,999 of common stock By Investing.com - Investing.com Nigeria
Form 4 Cardiff Oncology Inc For: 16 July By Investing.com - Investing.com Nigeria
Cardiff Oncology Director Purchased Shares Worth Over $999K - TradingView
Cardiff Oncology Insider Bought Shares Worth $1,000,000, According to a Recent SEC Filing - marketscreener.com
Cardiff Oncology (CRDF) director buys 687,285 shares and warrants - Stock Titan
Cardiff Oncology (CRDF) CEO adds common shares and new warrants stake - Stock Titan
Cardiff Oncology Raises $10M for Onvansertib Regulatory Push - AllSci
Cardiff Oncology Announces $10 Million Registered Direct Offering to Advance Cancer Therapy Pipeline - Minichart
Cardiff Oncology Raises $10.05 Million in Registered Offering; Engages H.C. Wainwright - TradingView
Cardiff Oncology (Nasdaq: CRDF) closes $10.05M direct offering - Stock Titan
Cardiff Oncology (NASDAQ: CRDF) prices $10.05M share and warrant financing - Stock Titan
Cardiff Oncology announces $10M direct offering - MSN
Crude Oil Moves Lower; US Producer Prices Fall 0.3% In June - Sahm
Cardiff Oncology to Raise $10 Million in Share, Warrant Sale - Moomoo
Cardiff Oncology prices $10M registered direct offering - Investing.com UK
Cardiff Oncology prices $10M registered direct offering By Investing.com - Investing.com South Africa
Cardiff Oncology Announces $10 Million Registered Direct Offering to Strengthen Working Capital - Yahoo Finance
Cardiff Oncology Announces $10 Million Registered Direct Offering - The Manila Times
Cardiff Oncology Inc. (CRDF) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Enterprise value to EBIT forward of Cardiff Oncology, Inc. – FWB:XE7C - TradingView
CRDF Q1 2026 Earnings: EPS Miss Sends Mixed Signals Despite Modest Stock GainPerformance Review - dars.gov.et
Cardiff Oncology (CRDF) Noble Capital Markets Emerging Growth Virtual Investor Conference summary - Quartr
Price to earnings forward of Cardiff Oncology, Inc. – NASDAQ:CRDF - TradingView
Price to earnings forward of Cardiff Oncology, Inc. – TRADEGATE:XE7C - TradingView
Cardiff Oncology (CRDF) Rises 3.85% as Biotech Stock Tests Key Resistance ZoneDark Pool Sentiment - po-news-eg.net
Enterprise value to EBIT forward of Cardiff Oncology, Inc. – TRADEGATE:XE7C - TradingView
Price to book forward of Cardiff Oncology, Inc. – NASDAQ:CRDF - TradingView
Cardiff Oncology (CRDF) Falls as Stock Nears Critical Support ZoneCup and Handle - dars.gov.et
CRDFCardiff Oncology Inc Dividends - Finviz
Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cardiff Oncology Inc-Aktie (CRDF) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mohindru Mani | Chief Executive Officer |
Jul 14 '26 |
Buy |
1.46 |
34,364 |
50,000 |
59,067 |
| Mohindru Mani | Chief Executive Officer |
Jun 18 '26 |
Buy |
1.21 |
24,703 |
29,891 |
24,703 |
| PACE GARY W | Director |
Jun 18 '26 |
Buy |
1.22 |
30,000 |
36,600 |
1,356,376 |
1.84%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):